Stockreport

Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in Japan [Yahoo! Finance]

Akili, Inc.  (AKLI) 
PDF BOSTON, February 26, 2024 BUSINESS WIRE Akili , Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd ha [Read more]